Company Filing History:
Years Active: 2001
Title: The Innovative Contributions of Ling Chai in Peptide Compounds
Introduction: Ling Chai, an accomplished inventor based in Lexington, MA, has made significant strides in the field of biomedical innovations. Her groundbreaking work is recognized in the patent community, particularly for her contributions to peptide compounds that hold potential for modulating fibroblast growth factor receptor (FGFR) activity.
Latest Patents: Ling Chai holds a patent for “Peptide compounds useful for modulating FGF receptor activity.” This invention details peptide compounds capable of binding to either fibroblast growth factors (FGF) or fibroblast growth factor receptors (FGFR), specifically targeting FGFR2-IIIC and basic FGF. Notably, the peptide compound features a unique amino acid sequence designed to facilitate interaction with these receptors. Additionally, the invention encompasses pharmaceutical compositions containing these peptide compounds along with a pharmaceutically acceptable carrier. Methods for modulating FGFR activity through these peptide compounds are also included in the patent.
Career Highlights: Ling Chai's career is marked by her commitment to advancing medical science through innovative research. Her tenure at Praecis Pharmaceuticals, Inc. has allowed her to collaborate with leading professionals in the field, fostering an environment of creativity and exploration in peptide-based therapies.
Collaborations: Throughout her career, Ling Chai has worked alongside esteemed colleagues, including Howard Benjamin and Mark A. Findeis. Together, these professionals have contributed to the development of advanced therapeutic solutions that have the potential to impact patient care positively.
Conclusion: Ling Chai's innovative work in peptide compounds illustrates the vital role of inventors in progressing biomedical research. Her patent for modulating FGFR activity not only demonstrates her ingenuity but also signifies a promising avenue for future pharmaceutical applications. As the field of biomedicine continues to evolve, inventors like Ling Chai remain essential to driving innovation and improving healthcare outcomes.